Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 44,856 shares at $23.63 ($1.1M) on 2022-12-27, disclosed to the SEC on 2022-12-27.
Open-market sale of $1.1M COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 237 | $5K | 0.5% |
| 2 | $23.00 | 4,989 | $115K | 10.8% |
| 3 | $23.63 | 15,995 | $378K | 35.6% |
| 4 | $23.63 | 15,995 | $378K | 35.6% |
| 5 | $24.16 | 3,820 | $92K | 8.7% |
| 6 | $24.16 | 3,820 |
| $92K |
| 8.7% |
| Total | $23.65 avg | 44,856 | $1.1M | 100% |
| Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |
| COLL | SELL | 2020-05-15 | $804K | — | Filing → |